Methods for inspection of protein particles in a liquid beneficial agent

Patent metadata

Field	Value
Publication number	US-10132736-B2
Application number	US-201313841143-A
Country	US
Kind code	B2
Filing date	Mar 15, 2013
Priority date	May 24, 2012
Publication date	Nov 20, 2018
Grant date	Nov 20, 2018

Abstract

Detection of particles in a liquid beneficial agent contained within a container includes selectively illuminating at least a portion of the liquid beneficial, obtaining an image from the illuminated portion of the liquid beneficial agent, analyzing image data representing the image, using a data processor, to obtain a particle concentration, measuring an image intensity value of the image data using the data processor, and determining a quality level of the liquid beneficial agent using the data processor based on the particle concentration and the measured image intensity value.

First claim

We claim:

1. A method for inspecting a liquid beneficial agent contained within a container, comprising:
selectively illuminating at least a portion of the liquid beneficial agent having protein particles therein;
obtaining an image from the illuminated portion of the liquid beneficial agent;
analyzing image data representing the image, using a data processor, to identify a number of particles having a size greater than or equal to a particle size threshold to thereby obtain a particle concentration, wherein the particle size threshold represents the size at or above which particles can be counted by the data processor;
measuring an image intensity value of the image data, using the data processor, to detect particles having a size less than the particle size threshold, including determining a pixel intensity value of each pixel of a plurality of pixels of the image data and combining the pixel intensity values of the plurality of pixels to thereby determine the image intensity value;
determining a quality level of the liquid beneficial agent, using the data processor, by calculating an average molecular mass of the particles, wherein the average molecular mass is linearly proportional to the measured image intensity value and the particle concentration; and
packaging the liquid beneficial agent if the quality level is within a predetermined quality level range.

2. The method according to claim 1 , wherein selectively illuminating the portion of the liquid beneficial agent comprises focusing light through an optical element corresponding to the container to provide an undistorted image of the liquid beneficial agent.

3. The method according to claim 1 , wherein the liquid beneficial agent is selectively illuminated with light having a wavelength in a range from about 200 nm to about 1100 nm.

4. The method according to claim 1 , wherein the image is obtained by light scattering from particles in the illuminated portion of the liquid beneficial agent.

5. The method according to claim 1 , wherein the liquid beneficial agent has intrinsic fluorescence and the beneficial agent is selectively illuminated with light having an excitation wavelength suitable to cause the liquid beneficial agent to emit fluorescent light of an emission wavelength.

6. The method according to claim 5 , wherein obtaining the image comprises using an optical filter corresponding to the emission wavelength of the emitted fluorescent light.

7. The method according to claim 1 , wherein obtaining the image comprises focusing the image at an image detector through an optical element corresponding to the container to provide an undistorted image from the liquid beneficial agent.

8. The method according to claim 1 , wherein obtaining the image comprises:
capturing a first image and a second image from the illuminated portion of the liquid beneficial agent; and
using difference image analysis on the first image and the second image to obtain the image.

9. The method according to claim 1 , further comprising calibrating an image detector to a predetermined sensitivity.

10. The method according to claim 1 , wherein analyzing the image data to obtain the particle concentration is performed using a single image frame.

11. The method of claim 1 , wherein obtaining the particle concentration comprises counting a number of particles exceeding the particle size threshold to generate a particle size distribution.

12. The method of claim 11 , wherein counting a number of particles exceeding the particle size threshold comprises measuring particle scattering intensities to estimate the particle size distribution.

13. The method according to claim 1 , wherein determining the quality of the liquid beneficial agent further comprises comparing the particle concentration to a particle concentration threshold.

14. The method according to claim 13 , wherein determining the quality of the liquid beneficial agent further comprises comparing the image intensity value to an image intensity threshold.

15. The method according to claim 1 , wherein the average molecular mass of the particles is calculated by reducing the image intensity value by an intensity background value to obtain a reduced image intensity value, and dividing the reduced image intensity value by an instrument constant and the particle concentration.

16. The method according to claim 1 , further comprising providing an indication to a user that the liquid beneficial agent is acceptable if the quality level is within a predetermined quality level range.

Assignees

• Abbvie Inc

Inventors

• Matayoshi Edmund
• Wang Jie

Classifications

• G01N21/6456

  Spatial resolved fluorescence measurements; Imaging · CPC title

• G01N15/06

  Investigating concentration of particle suspensions (by weighing G01N5/00; investigating sedimentation of particle suspensions G01N15/04; investigating individual particles G01N15/10) · CPC title

• G01N21/9027

  in containers after filling · CPC title

• G01N2015/0693

  Physics · mapped topic

• C07K16/241

  Tumor Necrosis Factors · CPC title